February 24, 2026

Researcher's Alert March 2, 2026

Office of the Vice President for Research Affairs

 

Announcements


NIH –Reminder of Requirement of Certification of IRB Approval

This Notice is to remind the extramural research community that NIH requires certification that all nonexempt human subjects research has been reviewed and approved by an appropriate Institutional Review Board (IRB).  Applicants must submit the date of final IRB approval, which is the date that all protocols in the proposed research application received IRB review and approval (i.e., the date of the last protocol approval).  Submission of pending (e.g., conditional, pre-approval, interim) or expired IRB approval dates is not acceptable. NIH will not allow any funds to be used by recipients for nonexempt human subject’s research where certification via final IRB approval date has not been provided to the funding Institutes, Centers, and Offices (ICO).


Reminder of Requirement for Certification of IRB Approval
(NOT-OD-26-043)

 

 

Funding Opportunities

If you're considering applying for grants, whether it's research, community-focused, technology-related, or something else, below you will find Funding Opportunity information to help guide you.

 

Call for Concept Papers: W.M. Keck Foundation 

Loma Linda University Health is accepting institutional submissions of concept papers to the W.M. Keck Foundation Research Program. The Keck Foundation funds high-impact research in basic physical, life, and biomedical sciences, including instrumentation development and engineering approaches in service of answering basic scientific questions.

We invite investigators conducting basic science research to submit a one-page concept paper (12 point font with 1 inch margins) that must include:

  1. Organization Name
  2. Project Title
  3. Full name of Principal Investigator
  4. An overview of the proposed project emphasizing any unique aspects and pilot studies
  5. Methodologies
  6. Key Personnel
  7. Knowledge Gap: what is the basic scientific question to be answered?
  8. Impact: if successful, what will be enabled and who will benefit?
  9. Innovation: how is the proposed work distintive, innovative, field-expanding, or paradigm shifting?
  10. Fit: Please see our funding guidelines for details on what we do and do not fund.
  11. Budget: broken down, if possible, by major areas, e.g. personnel, equipment, consumable supplies, etc. The budget must be reviewed by LLU Pre Award before submission. Please contact Fanny Miranda at fmiranda@llu.edu for a budget consultation. 
  12. If a reference is necessary, use a footnote and abbreviate it as (Author, Science, 323, 45, ‘11). DO NOT USE (Jones et al., 2011). Please avoid any illustrations.

Please see the full submission guidelines here: https://www.wmkeck.org/research-application-process/#concept

Submission Deadline: May 1, 2026
Submit to: Sunny Han at sunnyhan@llu.edu
Subject Line: Keck Foundation Concept Proposal – [PI Last Name]

An institutional nominating committee will review submissions and select proposals to move forward. You are welcome to circulate the flyer Keck Foundation Call for Concept Papers.pdf with your department and colleagues. Please contact Sunny Han at sunnyhan@llu.edu with any questions.

 

Harrington Discovery Institute

Rare Disease Scholar Award- Seeks novel approaches to treat rare diseases. Proposals of interest to include discoveries demonstrating rigorous science, innovation, and potential impact. Currently focus on neurological disorders, developmental disorders, and rare cancers but we welcome applications directed to other rare, genetic indications with a high unmet need.

 

American Heart Association

Heart Transplantation Research Network- To support a collaborative network of clinician investigators whose collective research efforts will lead management options for patients undergoing heart transplantation.

 

PFIZER

Research on Long-Acting Growth Hormone-To address knowledge gaps and unmet medical needs related to long-acting growth hormone treatment.

Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)- Seeking to fund sustainable projects that improve biomarker testing practices, strengthen targeted therapy selection, and support care teams in implementing patient-centered protocols.

Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator Therapy- Aimed to strengthen the competency of healthcare professionals involved in the management of adults with ulcerative colitis who are initiating S1Prm therapy.

Advances in Migraine Management- Identify and address the educational needs of healthcare professionals to improve the care, management, and outcomes of adult patients with migraine.

 

Centers For Medicare & Medicaid Services (CMS)

Advancing Chronic Care with Effective, Scalable Solutions (ACCESS)- To expand access to new technology-supported care options that help people improve their health and prevent and manage chronic disease.

 

NIH

Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) PAR-25-106- To encourage applicants to promote transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Should address overcoming major barriers in cancer biology and focus on mechanistic studies.

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) PAR-25-362-To further elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonate, infant, and children adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics.

NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) PA-26-002- To support international research collaborations. This opportunity specifically implements an award structure of prime domestic awards with independent foreign awards that are linked to the prime.

 

T32’s

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) PA-25-168- To develop and/or enhance predoctoral and postdoctoral research training. To help ensure that a highly trained workforce is available to meet the needs of the Nation’s biomedical, behavioral, and clinical research agenda.

Medical Scientist Training Program T32 PAR-24-128- To develop a Pool of well-trained clinician-scientist leaders available to address the nation’s biomedical research needs.

National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32) PAR-23-228- To develop a pool of well-trained scientists available to address the nation’s biomedical research agenda. To allow appointed trainees to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor pr co-mentor.

Institutional Training Programs to Adbance Translational Research on Alzheimer’s Disease and AD-Related Dementias (T32 Clinical Trial Not allowed) PAR-25-247- To encourage biomedical, social, and behavioral research and research training directed toward greater understanding of the aging process and the diseases, special problems, and needs of people as they age.

Limited Competition: Ruth L. Kirschstein National Research Service (NRSA) Predoctoral Research Training Grant for the Clinical & Translational Science Awards Program (T32 Clinical Trial Not Allowed) PAR-25-194- To support predoctoral research training programs. To catalyze the generation of innovative methods and technologies that will enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of human disease and conditions.

Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant to the Clinical and Translational Science Awards Program (T32 Clinical Trial Not allowed) PAR-25-195- To support postdoctoral research training. To provide and disseminate clinical and translational science training and career support programs that enhance post doc research training.

For more NIH funding, click on the following link:https://grants.nih.gov/funding/nih-guide-for-grants-and-contracts

 

National Science Foundation (NSF)

Faculty Early Career Development Program (CAREER)-NSF 22-586-Supports early-career faculty who have the potential to serve as academic role models in research and education and to lead advances in the mission of their department or organization.

 

 

Forecasted Funding


Department of Defense (Managed by CDMRP)

The Ovarian Cancer Research Program released a pre-announcement for the following opportunities: Clinical Trial, Investigator-Initiated Research Award, Ovarian Cancer Academy-Early Career Investigator Award, Pilot Award. Click on the link below for more details.

The Pancreatic Cancer Research Program released a pre-announcement for the following funding opportunities: Focused Pilot Award, Idea Development Award, and Translational Research Partnership Award. Click on the link below for more details.

The Arthritis Research Program released a pre-announcement for the following funding opportunities: Clinical Research Award and Translational Research Award. Click on the link below for more details.

 

HRSA

Rural Residency Planning and Development (RRPD Program)- Estimated Post Date February 2026. To strengthen the physician workforce in rural communities. For more information about program expectations and past applications, click on the following link: https://simpler.grants.gov/opportunity/4b8c6fc1-6503-4e61-b939-bcfd0df080b6

Rural Communities Opioid Response Program (RCORP)-Planning-Estimated Post Date February 2026. Helps organizations conduct needs assessments, create partnerships, and develop plans for sustainable prevention, treatment, and recovery services. For more information, click on the link below.

https://www.grants.gov/search-results-detail/361018

 

Centers for Medicare & Medicaid Services (CMS)

MAHA ELEVATE (Make America Healthy Again)-CMS will release a NOFO in early 2026 for the first cohort. The proposals will utilize evidence-based, whole-person care approaches, including functional or lifestyle medicine interventions. For more information, click on the link below.

https://www.cms.gov/priorities/innovation/innovation-models/maha-elevate

 

Share